ChadMMichenerMDFACOG

Gynecologic Oncology

Vice Chair, Obstetrics/ Gynecology Institute | Chair, Dept of Subspecialty Care for Women’s Health | Professor of OB/GYN and Reproductive Biology, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University

Join to view full profile

Dr. Michener is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Michener's full profile

Already have an account?

Office
9500 Euclid Ave
Cleveland, OH 44195
Phone+1 800-223-2273

Fax+1 216-444-8551

Summary

-Vice Chair, Obstetrics and Gynecology Institute
-Chair, Dept of Subspecialty Care for Women’s Health
-Professor of Ob/Gyn and Reproductive Biology Cleveland Clinic Lerner College of Medicine of Case Western University.
-Fellow, American College of Obstetricians and Gynecologists and a member of the Society of Gynecologic Oncologists.
-Staff, Gynecologic Oncology

Education & Training

Cleveland Clinic FoundationFellowship, Gynecologic Oncology, 2002 - 2004
National Cancer InstitutePost-Doctoral Fellowship, 2001 - 2002
TriHealth (Bethesda Hospital)Residency, Obstetrics and Gynecology, 1997 - 2001
Wright State University Boonshoft School of MedicineClass of 1997

Certifications & Licensure

OH State Medical License 1998 - 2026
MD State Medical License 2001 - 2003
KY State Medical License 1999 - 2000
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Fellow (FACS) American College of Surgeons
Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Clinical Trials

Randomized Phase II Study of Intravenous 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (3-AP, Triapine® NSC #663249) Cisplatin-Radiochemotherapy Versus Intravenous Cisplatin-Radiochemotherapy in Women Diagnosed With Stage IB-IVA Cervical Cancer and S Start of enrollment: 2013 Apr 01
Lymph Node Mapping in Patients With Newly Diagnosed Endometrial Cancer Undergoing Surgery Start of enrollment: 2013 Jul 01
Terminated
Not Applicable
A Study of Weekly Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With Safety Run-in (innovaTV 208) Start of enrollment: 2019 Mar 20
Completed
Phase 2
Artesunate Ointment for the Treatment of High Grade Vulvar Intraepithelial Neoplasia (HSIL VIN2/3) Start of enrollment: 2019 Apr 17
Active, not recruiting
Phase 1
Join now to see all

Publications & Presentations

PubMed

Laparoscopic Cytoreduction After Neoadjuvant Chemotherapy in High-Grade Epithelial Ovarian Cancer: A LANCE Randomized Clinical Trial.
J Alejandro Rauh-Hain, Alexander Melamed, René Pareja, Taymaa May, Abdulrahman Sinno
JAMA Network Open. 2024-11-04
Extended-duration antibiotics are not associated with a reduction in surgical site infection in patients with ovarian cancer undergoing cytoreductive surgery with larg...
Julia Chalif, Laura M Chambers, Meng Yao, Michelle Kuznicki, Robert DeBernardo
Gynecologic Oncology. 2024-07-01
3 citations
Cell surface CD55 traffics to the nucleus leading to cisplatin resistance and stemness by inducing PRC2 and H3K27 trimethylation on chromatin in ovarian cancer.
Rashmi Bharti, Goutam Dey, Debjit Khan, Alex Myers, Olivia G Huffman
Molecular Cancer. 2024-06-10

Press Mentions

Hillcrest Hospital Opens New Obstetrics Emergency DepartmentNovember 26th, 2021
Cleveland Clinic Names Tristi Muir, M.D., Chair of Ob/Gyn & Women’s Health InstituteSeptember 8th, 2021
Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3) (ART-CIN_IIB)September 23rd, 2019
Join now to see all